The Effect of Nonstress Test Device Noise Level on Stress Parameters in Primiparous Pregnant Women

August 3, 2022 updated by: Halic University

Introduction: Prenatal tests can increase the stress levels of pregnant women. One of the tests performed to evaluate fetal health during pregnancy is the Nonstress Test (NST).

Objective: To evaluate the effect of NST device noise level on stress parameters in primiparous pregnant women.

Method: A randomized controlled, prospective study was conducted with 44 pregnant women in a State Hospital in Istanbul/Turkey between 01.02.2021 and 01.10.2021.

Personal Information Form, Spielberger State Anxiety Inventory, Hillrom Welch Allyn Connex Spot Monitor, Gluco Dr Glucometer, Extech SL 400 Personal Noise Dosimeter, Sennheiser HD 450BT ANC Over-Ear Bluetooth Headset, Eppendorf Tube, Philips Avalon FM20 NST were used to collect data. A p value of <.05 was considered significant in the statistical evaluation.

Study Overview

Detailed Description

A number of tests are used to evaluate fetal health during pregnancy. One of these tests is the NST. NST is a frequently used fetal evaluation method in gynecology clinics/services during pregnancy and labor. The sound levels of the NST device are created in a way that the healthcare professional can adjust, and at the same time, the average dB(A) range of the sound levels is not known. It has been stated in many studies that noise causes stress in individuals, and that the stress experienced in pregnant women is associated with negative maternal and neonatal outcomes. It is important to evaluate NST noise levels and stress parameters in order to maintain NST, which is a frequently used fetal evaluation method in the prenatal period in clinical practice, without causing maternal stress and to prevent possible negative consequences. With the information to be obtained in line with the results of the research, it is aimed to maintain the noise level of the NST device used by the midwives in the most appropriate sound range for the pregnant women and thus to ensure that the stress levels of the pregnant women are at the lowest level during the procedure.

This study was carried out to evaluate the effect of NST device noise level on stress parameters in primiparous pregnant women.

Study Type

Observational

Enrollment (Actual)

44

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Istanbul, Turkey
        • Bakırköy Dr. Sadi Konuk Training and Research Hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 45 years (Adult)

Accepts Healthy Volunteers

N/A

Genders Eligible for Study

Female

Sampling Method

Probability Sample

Study Population

It was decided to make the minimum sample size required in the study by power analysis, taking into account the differences of the pre-test and post-test variables, which are the primary results. More than 2 groups analysis (ANOVA) test in repeated measurements in the calculation, effect size: 0.25, type 1 error rate (α)=0.05, power of the study (1- β) was 0.80 (Type II error= 0.20). Accordingly, the minimum number of samples to be reached was calculated as 40 in total, and the study was completed with 44 samples, taking into account the 10% risk of loss.

Description

Inclusion Criteria:

  • Voluntarily agreeing to participate in the research,
  • Over 18 years old,
  • Literate,
  • Fluent in Turkish
  • 32-42 of your pregnancy. in the week,
  • Having a healthy pregnancy,
  • No adrenal insufficiency,
  • No problems with hearing,
  • No psychiatric diagnosis during or before pregnancy,
  • No history of infertility,
  • Coming to routine pregnancy and NST control,
  • Have not had any food or drink for at least two hours before the procedure,
  • Primiparous pregnant women without contractions were included.

Exclusion Criteria:

  • Pregnant women whose contractions are detected during the NST procedure,
  • Pregnant women with deceleration detected in the NST procedure were excluded from the study.

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Case-Control
  • Time Perspectives: Prospective

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
CONTROL GROUP
Control Group [NST device volume turned off]

Pre-Test (0-2 minutes before NST starts) - Measurement of vital parameters (Pre-Test)

  • Glucose measurement
  • Taking Salivary Cortisol and Saliva ACTH samples
  • Filling the Spielberger State Anxiety Inventory

    • Starting NST by controlling the noise level Interim Test-(NST 10th minute) - Measurement of vital parameters (Intermediate Test)

  • Taking Salivary Cortisol and Saliva ACTH samples
  • Filling the Spielberger State Anxiety Inventory

    • Termination of NST after 20 minutes Final Test(within 0-2 minutes after NST is over)

  • Measurement of vital parameters
  • Glucose measurement
  • Taking Salivary Cortisol and Saliva ACTH samples
  • Filling the Spielberger State Anxiety Inventory After Data Collection - Recording of data
  • Centrifugation and analysis of saliva samples taken
Intervention Group I
Intervention Group I [NST device volume 1-35 dB(A)]

Pre-Test (0-2 minutes before NST starts) - Measurement of vital parameters (Pre-Test)

  • Glucose measurement
  • Taking Salivary Cortisol and Saliva ACTH samples
  • Filling the Spielberger State Anxiety Inventory

    • Starting NST by controlling the noise level Interim Test-(NST 10th minute) - Measurement of vital parameters (Intermediate Test)

  • Taking Salivary Cortisol and Saliva ACTH samples
  • Filling the Spielberger State Anxiety Inventory

    • Termination of NST after 20 minutes Final Test(within 0-2 minutes after NST is over)

  • Measurement of vital parameters
  • Glucose measurement
  • Taking Salivary Cortisol and Saliva ACTH samples
  • Filling the Spielberger State Anxiety Inventory After Data Collection - Recording of data
  • Centrifugation and analysis of saliva samples taken
Intervention Group II
Intervention Group II [NST device volume 36-60 dB(A)]

Pre-Test (0-2 minutes before NST starts) - Measurement of vital parameters (Pre-Test)

  • Glucose measurement
  • Taking Salivary Cortisol and Saliva ACTH samples
  • Filling the Spielberger State Anxiety Inventory

    • Starting NST by controlling the noise level Interim Test-(NST 10th minute) - Measurement of vital parameters (Intermediate Test)

  • Taking Salivary Cortisol and Saliva ACTH samples
  • Filling the Spielberger State Anxiety Inventory

    • Termination of NST after 20 minutes Final Test(within 0-2 minutes after NST is over)

  • Measurement of vital parameters
  • Glucose measurement
  • Taking Salivary Cortisol and Saliva ACTH samples
  • Filling the Spielberger State Anxiety Inventory After Data Collection - Recording of data
  • Centrifugation and analysis of saliva samples taken
Intervention Group III
Intervention Group III [61 dB( A) and above]

Pre-Test (0-2 minutes before NST starts) - Measurement of vital parameters (Pre-Test)

  • Glucose measurement
  • Taking Salivary Cortisol and Saliva ACTH samples
  • Filling the Spielberger State Anxiety Inventory

    • Starting NST by controlling the noise level Interim Test-(NST 10th minute) - Measurement of vital parameters (Intermediate Test)

  • Taking Salivary Cortisol and Saliva ACTH samples
  • Filling the Spielberger State Anxiety Inventory

    • Termination of NST after 20 minutes Final Test(within 0-2 minutes after NST is over)

  • Measurement of vital parameters
  • Glucose measurement
  • Taking Salivary Cortisol and Saliva ACTH samples
  • Filling the Spielberger State Anxiety Inventory After Data Collection - Recording of data
  • Centrifugation and analysis of saliva samples taken

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Does increasing the noise level of the NST device affect If salivary cortisol levels
Time Frame: 01.02.2021-01.10.2021
Data collection tool used to reach this outcome: Saliva cortisol was measured by a microplate reader with commercially available kit based on ELISA.
01.02.2021-01.10.2021
Does increasing the noise level of the NST device affect If salivary ACTH levels
Time Frame: 01.02.2021-01.10.2021
Data collection tool used to reach this outcome: Saliva ACTH was measured by a microplate reader with commercially available kit based on ELISA.
01.02.2021-01.10.2021

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Study Director: Ayşenur Turan, PhD, lecturer

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

February 1, 2021

Primary Completion (Actual)

October 1, 2021

Study Completion (Anticipated)

July 28, 2028

Study Registration Dates

First Submitted

July 26, 2022

First Submitted That Met QC Criteria

August 3, 2022

First Posted (Actual)

August 4, 2022

Study Record Updates

Last Update Posted (Actual)

August 4, 2022

Last Update Submitted That Met QC Criteria

August 3, 2022

Last Verified

August 1, 2022

More Information

Terms related to this study

Other Study ID Numbers

  • 35620

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

Undecided

IPD Plan Description

It is not yet known if there will be a plan to make IPD available.

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Stress

Clinical Trials on Stress Parameters Measurement

Subscribe